<DOC>
	<DOC>NCT00265252</DOC>
	<brief_summary>To determine the cumulative incidence of total hip replacement, time to event after treatment with Fosamax or placebo during the study peroid</brief_summary>
	<brief_title>Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis</brief_title>
	<detailed_description>To determine the cumulative incidence of total hip replacement and collpase of femoral head, time to event after treatment with Fosamax or placebo during the study peroid</detailed_description>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>osteonecrosis of femoral head be able to provide singed informed consent prior bisphosphonate use pregnant or lactating woman bilateral hip replacement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>osteonecrosis</keyword>
	<keyword>total hip replacement</keyword>
</DOC>